New drug CSL040 takes first step in human safety trial
NCT ID NCT05937581
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of a new drug called CSL040 in 62 healthy adults. The goal was to see if the drug is safe and how the body processes it. This is the first time CSL040 has been given to humans, and it is being developed for diseases where the immune system attacks the body.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLEMENT-MEDIATED DISORDERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network Pty Ltd
Herston, Queensland, 4006, Australia